Predicting Antibody Developability From Sequence Using Machine Learning
Source: Dassault Systèmes
Antibodies have become prominent therapeutic agents but are costly to develop. Existing approaches to predict developability depend on structure, which requires extensive laboratory or computational work to obtain. To address this issue, we developed a machine learning model to predict developability from sequence alone by extracting physicochemical and learned embedding features. Our model achieves high sensitivity and specificity on a dataset of 2400 antibodies. These results suggest that sequence is predictive of developability, enabling more efficient development of antibodies.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online
Dassault Systèmes
This website uses cookies to ensure you get the best experience on our website. Learn more